I would add a couple of Qs:
1. What happened to the interest from Europe for AML trials?
2. Are we designing AML trials also to measure cardio protection and FTO inhibition?
3. At what point do we want to trial cardio protection in Europe/ US? Phase 2?
Thanks.
I would add a couple of Qs:1. What happened to the interest from...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.040(2.34%) |
Mkt cap ! $311.6M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.96 | $1.75 | $642.6K | 344.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5855 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 6072 | 2 |
View Market Depth
| Last trade - 12.35pm 26/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |